Q2049 Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg

Short descriptor: Imported lipodox inj

✓ Active HCPCS Level II 2026
Open Q2049 in the app →

Look up Q2049 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q2049 is the HCPCS Level II code for Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Lump-sum purchase of DME, prosthetics, orthotics
Effective Date
2012-07-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q2049 with the canonical source and edition:

Q2049 — Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q2049

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q2049

Related Codes in Section Q

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial